help_outline Skip to main content

News / Articles

Association between Early Treatment with Qingfei Paidu Decoction and Favorable Clinical Outcomes in

Nannan Shi et al.  | Published on 12/29/2020
The coronavirus disease 2019 (COVID-19) epidemic has been almost controlled in China under a series of policies, including “early diagnosis and early treatment”. This study aimed to explore the association between early treatment with Qingfei Paidu decoction (QFPDD) and favorable clinical outcomes. In this retrospective multicenter study, we included 782 patients (males, 56 %; median age 46) with confirmed COVID-19 from 54 hospitals in nine provinces of China, who were divided into four groups according to the treatment initiation time from the first date of onset of symptoms to the date of starting treatment with QFPDD. Read more here.

All News / Articles